73024-87-0 Usage
Uses
Used in Pharmaceutical Industry:
PGLU-ASN-GLY is used as a therapeutic agent for its potential role in protein synthesis and regulation. The specific sequence of amino acids may offer targeted effects on protein folding, stability, and function, making it a candidate for the development of drugs that address specific protein-related disorders.
Used in Nutraceutical Industry:
PGLU-ASN-GLY is used as a dietary supplement to support protein synthesis and overall health. The presence of essential amino acids in this peptide may contribute to muscle growth, tissue repair, and general well-being.
Used in Cosmetic Industry:
PGLU-ASN-GLY is used as an ingredient in skincare products for its potential role in promoting collagen synthesis and skin elasticity. The peptide's influence on protein structure and function may help improve skin health and appearance.
Used in Research Applications:
PGLU-ASN-GLY is used as a research tool in biological and medical studies. The peptide's specific amino acid composition allows scientists to investigate the mechanisms of protein synthesis, folding, and stability, furthering our understanding of protein-related diseases and potential therapeutic interventions.
Check Digit Verification of cas no
The CAS Registry Mumber 73024-87-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,0,2 and 4 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 73024-87:
(7*7)+(6*3)+(5*0)+(4*2)+(3*4)+(2*8)+(1*7)=110
110 % 10 = 0
So 73024-87-0 is a valid CAS Registry Number.
73024-87-0Relevant articles and documents
SYNTHESIS OF A SUGGESTED AGGRESSION PEPTIDE
Sorochinskaya, E. I.,Leont'eva, L. I.,Martynov, V. F.
, p. 216 - 217 (2007/10/02)
Four different schemes for the synthesis by the classical method of pyroglutamylasparaginylglycine - a suggested aggression peptide have been described.The best is a scheme using C- and N-terminal protective groups of the benzyl type at the stage of obtaining the protected tripeptide.Literature information according to which the compound possesses biological activity has been refuted.